Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, and pain in the abdomen and joint and muscle pain.
The Schistosomiasis pipeline drugs market research report provides an analysis of the Schistosomiasis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects.
Key Targets of the Schistosomiasis Pipeline Drugs Market
Some of the targets of the Schistosomiasis pipeline drugs market are Bacterial Cell Membrane, Toll Like Receptor 2, and Toll Like Receptor 4.
Schistosomiasis Pipeline Drugs Market, by Key Targets
For more insights on key targets, download a free report sample
Key Mechanisms of Action in the Schistosomiasis Pipeline Drugs Market
The key mechanisms of action of the Schistosomiasis pipeline drugs market are Bacterial Cell Membrane Disruptor, Toll Like Receptor 2 Agonist, and Toll Like Receptor 4 Agonist.
Schistosomiasis Pipeline Drugs Market, by Mechanisms of Action
For more insights on key targets, download a free report sample
Key Routes of Administration in the Schistosomiasis Pipeline Drugs Market
The routes of administration in the Schistosomiasis pipeline drugs market are intramuscular, oral, and intrauterine.
Schistosomiasis Pipeline Drugs Market, by Routes of Administration
For more insights on routes of administration, download a free report sample
Key Molecule Types in the Schistosomiasis Pipeline Drugs Market
The molecule types in the Schistosomiasis pipeline drugs market are Small Molecule, Vaccine, DNA Vaccine, and Subunit Vaccine.,
Schistosomiasis Pipeline Drugs Market, by Molecule Types
For more insights on molecule type, download a free report sample
Key Companies in the Schistosomiasis Pipeline Drugs Market
Some of the key companies in the Schistosomiasis pipeline drugs market are Merck KGaA, Villya Pharmaceuticals, Helix Biogen Institute, Pai Life Sciences Inc, Tongli Biomedical Co Ltd, Albert B. Sabin Vaccine Institute Inc, Farmabrasilis, Oswaldo Cruz Foundation and Salvensis among others.
Schistosomiasis Pipeline Drugs Market, by Key Companies
For more insights on molecule type, download a free report sample
Schistosomiasis Pipeline Drugs Market Report Overview
Key Targets | Bacterial Cell Membrane, Toll Like Receptor 2, and Toll Like Receptor 4 |
Key Mechanisms of Action | Bacterial Cell Membrane Disruptor, Toll Like Receptor 2 Agonist, and Toll Like Receptor 4 Agonist |
Key Routes of Administration | Intramuscular, Oral, and Intrauterine |
Key Molecule Types | Small Molecule, Vaccine, DNA Vaccine, and Subunit Vaccine |
Key Companies | Merck KGaA, Villya Pharmaceuticals, Helix Biogen Institute, Pai Life Sciences Inc, Tongli Biomedical Co Ltd, Albert B. Sabin Vaccine Institute Inc, Farmabrasilis, Oswaldo Cruz Foundation and Salvensis |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Schistosomiasis (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Schistosomiasis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Schistosomiasis (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Schistosomiasis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Schistosomiasis (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Schistosomiasis (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Schistosomiasis (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Merck KGaA
Pai Life Sciences Inc
Tongli Biomedical Co Ltd
Villya Pharmaceuticals
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Schistosomiasis pipeline drugs market?
Some of the targets of the Schistosomiasis pipeline drugs market are Bacterial Cell Membrane, Toll Like Receptor 2, and Toll Like Receptor 4.
-
What are the mechanisms of action of the Schistosomiasis pipeline drugs market?
The key mechanisms of action of the Schistosomiasis pipeline drugs market are Bacterial Cell Membrane Disruptor, Toll Like Receptor 2 Agonist, and Toll Like Receptor 4 Agonist.
-
What are the routes of administration in the Schistosomiasis pipeline drugs market?
The routes of administration in the Schistosomiasis pipeline drugs market are intramuscular, oral, and intrauterine.
-
What are the molecule types in the Schistosomiasis pipeline drugs market?
The molecule types in the Schistosomiasis pipeline drugs market are Small Molecule, Vaccine, DNA Vaccine, and Subunit Vaccine.
-
Which are the key companies in the Schistosomiasis pipeline drugs market?
Some of the key companies in the Schistosomiasis pipeline drugs market are Merck KGaA, Villya Pharmaceuticals, Helix Biogen Institute, Pai Life Sciences Inc, Tongli Biomedical Co Ltd, Albert B. Sabin Vaccine Institute Inc, Farmabrasilis, Oswaldo Cruz Foundation and Salvensis among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.